Fifteen-year survivor of renal cell carcinoma after metastasectomies for multiple bone metastases

Orthopedics

Volumn 36, Issue 11, 2013, Pages

  Kato, Satoshi ^a   Murakami, Hideki ^a   Takeuchi, Akihiko ^a   Demura, Satoru ^a   Yoshioka, Katsuhito ^a   Kawahara, Norio ^b   Tomita, Katsuro ^a   Tsuchiya, Hiroyuki ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 2;

ADULT; ARTICLE; BONE METASTASIS; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; CURETTAGE; HUMAN; HUMERUS METASTASIS; KIDNEY CARCINOMA; LUNG METASTASIS; MALE; METASTASIS RESECTION; MIDDLE AGED; MULTIPLE BONE METASTASIS; NEPHRECTOMY; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; SOLITARY SPINAL METASTASIS; SPINE METASTASIS; SURGICAL APPROACH; SURGICAL INFECTION; THORAX RADIOGRAPHY;

BONE NEOPLASMS; CARCINOMA, RENAL CELL; HUMANS; HUMERUS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; THORACIC VERTEBRAE;

EID: 84889595036     PISSN: 01477447     EISSN: None     Source Type: Journal    
DOI: 10.3928/01477447-20131021-32     Document Type: Article

References (22)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300.
2. Bukowski RM. Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2. Cancer. 1997; 80(7):1198-1220.
3. Motzer RJ, Michaelson MD, Redman BG, et al. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma. J Clin Oncol. 2006; 24(1):16-24.
4. Negrier S, Escudier B, Gomez F, et al. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunotherapie. Ann Oncol. 2002; 13(9):1460-1468.
5. Naito S, Yamamoto N, Takayama T, et al. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients. Eur Urol. 2010; 57(2):317-325.
6. Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol. 2000; 163(2):408-417.
7. Fyfe G, Fisher RI, Rosenberg SA, Sznol M, Parkinson DR, Louie AC. Results of treat-ment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy. J Clin Oncol. 1995; 13(3):688-696.
8. Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med. 2005; 353(23):2477-2490.
9. Motzer RJ, Hutson TE, Tomczak P, et al. Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009; 27(22):3584-3590.
10. Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastasis from renal cell carcinoma. Cancer. 2011; 117(13):2873-2882.
11. Kavolius JP, Mastorakos DP, Pavlovich C, Russo P, Burt ME, Brady MS. Resection of metastatic renal cell carcinoma. J Clin Oncol. 1998; 16(6):2261-2266.
12. Breau RH, Blute ML. Surgery for renal cell carcinoma metastases. Curr Opin Urol. 2010; 20(5):375-381.
13. Hofmann HS, Neef H, Krobe K, Andreev P, Silber RE. Prognostic factors and survival after pulmonary resection of metastatic renal cell carcinoma. Eur Urol. 2005; 48(1):77-88.
14. Piltz S, Meimarakis G, Wichmann MW, Hatz R, Schildberg FW, Fuerst H. Long-term results after pulmonary resection of renal cell carcinoma metastases. Ann Thorac Surg. 2002; 73(4):1082-1087.
15. Lin PP, Mirza AN, Lewis VO, et al. Patient survival after surgery for osseous metastases from renal cell carcinoma. J Bone Joint Surg Am. 2007; 89(8):1794-1801.
16. Jung ST, Ghert MA, Harrelson JM, Scully SP. Treatment of osseous metastases in patients with renal cell carcinoma. Clin Orthop Relat Res. 2003; 409:223-231.
17. Althausen P, Althausen A, Jennings LC, Mankin HJ. Prognostic factors and surgical treatment of osseous metastases secondary to renal cell carcinoma. Cancer. 1997; 80(6):1103-1109.
18. Kume H, Kakutani S, Yamada Y, et al. Prognostic factors for renal cell carcinoma with bone metastasis: who are the long-term survivors? J Urol. 2011: 185(5):1611-1614.
19. Tomita K, Kawahara N, Baba H, Tsuchiya H, Nagata S, Toribatake Y. Total en bloc spondylectomy for solitary spinal metastasis. Int Orthop. 1994; 18(5):291-298.
20. Boriani S, Biagini R, De Iure F, et al. En bloc resections of bone tumors of the thoracolumbar spine. A preliminary report on 29 patients. Spine (Phila Pa 1976). 1996; 21(16):1927-1931.
21. Wang J, Talmon GA, Feloney M, Morris MC. Twelve-year survival after multiple recurrences and repeated metastasectomies for renal cell carcinoma. World J Surg Oncol. 2011; 9:155.
22. Baloch KG, Grimer RJ, Carter SR, Tillman RM. Radical surgery for the solitary bony metastasis from renal-cell carcinoma. J Bone Joint Surg Br. 2000; 82(1):62-67.